EXTENT AND DIVERSITY OF INFLAMMATORY CELL INFILTRATES IN SQUAMOUS-CELL CARCINOMAS AND BASAL-CELL EPITHELIOMAS OF THE HEAD AND NECK

被引:10
作者
LIEBAU, D [1 ]
LONING, T [1 ]
ARPS, H [1 ]
机构
[1] UNIV HAMBURG, INST PATHOL, MARTINISTR 52, D-2000 HAMBURG 20, FED REP GER
关键词
D O I
10.1111/j.1600-0714.1987.tb00689.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Using monoclonal antibodies reactive with Langerhans'' cells (LCs), macrophages, and T cell subpopulations, the density and proportions of cells of the immune system of the normal oral mucosa were determined immunohistochemically, and compared with findings in oral squamous cell carcinomas (SCC) and basal cell epitheliomas (BCE). In normal oral epithelia, the dominant cell type was the LC, positive for CD 1, and expressing HLA-DR antigens (DR+). Many intraepithelial cells were lymphocytes of the suppressor/cytotoxic phenotype (CD 8+), which was also the most prominent cell type in the normal mucosal stroma. Significant differences were observed for the content of CD 8-, OKM 1-, and CD 4-positive cells in the epithelium of normal oral mucosa, SCC, and BCE, and for the amount of CD 1-positive Langerhans cells in the connective tissue of the different groups of tissues. When CD 4/CD 8 ratios were calculated, differences between SCC and BCE became most evident. A CD 4/CD 8 ratio greater 0.5 was seen to be characteristic for BCE. Thus, in contrast to the striking preponderance of suppressor/cytotoxic lymphocytes (CD 8+) in SCC, BCE showed typically almost balanced numbers of suppressor/cytotoxic (CD 8+) and helper/inducer (CD 4+) lymphocytes. This finding further underlines the biological differences recognized between these most common neoplasias of the head and neck.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 58 条
[31]   IDENTIFICATION OF INFLAMMATORY CELL PHENOTYPES IN HUMAN ORAL CARCINOMAS BY MEANS OF MONOCLONAL-ANTIBODIES [J].
LONING, T ;
BROEMEL, H ;
BECKER, WM ;
OTTO, HF .
ARCHIVES OF ORAL BIOLOGY, 1983, 28 (12) :1093-1100
[32]   PLASMA-CELLS AND IMMUNOGLOBULIN-SYNTHESIS IN ORAL PRE-CANCER AND CANCER - CORRELATION WITH DYSPLASIA, CANCER DIFFERENTIATION, RADIOTHERAPY AND CHEMOTHERAPY [J].
LONING, T ;
BURKHARDT, A .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1979, 384 (01) :109-120
[33]   IDENTIFICATION OF LANGERHANS CELLS - SIMULTANEOUS USE OF SERA TO INTERMEDIATE FILAMENTS, T6 AND HLA-DR ANTIGENS ON ORAL-MUCOSA, HUMAN-EPIDERMIS AND THEIR TUMORS [J].
LONING, T ;
CASELITZ, J ;
SEIFERT, G ;
WEBER, K ;
OSBORN, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1982, 398 (02) :119-128
[34]  
LONING T, 1982, THESIS U HAMBURG
[35]   QUANTITATIVE ASSESSMENT OF LANGERHANS CELLS IN ACTINIC KERATOSIS, BOWENS DISEASE, KERATOACANTHOMA, SQUAMOUS-CELL CARCINOMA AND BASAL-CELL CARCINOMA [J].
MCARDLE, JP ;
KNIGHT, BA ;
HALLIDAY, GM ;
MULLER, HK ;
ROWDEN, G .
PATHOLOGY, 1986, 18 (02) :212-216
[36]   DEMONSTRATION INSITU OF T-CELLS AND T-CELL SUBSETS IN LICHEN PLANUS USING MONOCLONAL-ANTIBODIES [J].
MCMILLAN, EM ;
MARTIN, D ;
WASIK, R ;
EVERETT, MA .
JOURNAL OF CUTANEOUS PATHOLOGY, 1981, 8 (03) :228-234
[37]  
MEISSNER K, IN PRESS VIRCHOW ARC
[38]   SUPPRESSOR MECHANISMS AND THEIR SIGNIFICANCE IN TUMOR IMMUNOLOGY [J].
MIKULSKI, SM ;
MUGGIA, FM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1978, 4 (03) :139-142
[39]  
MURPHY GF, 1981, LAB INVEST, V45, P465
[40]  
Otto H F, 1973, Curr Top Pathol, V57, P81